France· FR:65014058
ALIZEM 30 mg, capsule molle
A medicinal product containing alitrétinoïne, registered in France by PIERRE FABRE MEDICAMENT, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ALITRÉTINOÏNE
- Manufacturer
- PIERRE FABRE MEDICAMENT
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930176023plaquettes PVC PVDC aluminium de 30 capsules mollesEUR 184.11
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alitrétinoïne in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenAlitretinoin Ebb 30 mg Kapsel, mjukEbb Medical AB
- SpainALITRETINOINA IFC 30 MG CAPSULAS BLANDAS EFGIndustrial Farmaceutica Cantabria S.A.
- NorwayAlitretinoin OrifarmOrifarm Generics A/S
- FinlandAlitretinoin OrifarmOrifarm Generics A/S
- SwitzerlandAlitrecutan
- BelgiumAlitretinoin Orifarm 30 mgOrifarm Generics
- PolandToctinoStiefel Laboratoires Legacy (Ireland) Ltd.
- NetherlandsAlipalmtin 10 mg zachte capsulesOrifarm Healthcare A/S
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Alitretan, Toctino
- Belgium · Alitretinoin Orifarm
- Germany · Alitrederm, Toctino
- Denmark · Alitretinoin Orifarm, Toctino
- Spain · Alitretinoína Ifc, Toctino
- Finland · Alitretinoin Orifarm, Toctino
- United Kingdom (Northern Ireland) · Alitretinoin Ennogen Healthcare, Alitretinoin Ennogen Ip
- Italy · Alitrecare, Toctino
- Netherlands · Alipalmtin, Alitretinoïne Ifc
- Norway · Alitretinoin Orifarm, Toctino
- Portugal · Alitretinoína Cantabria
- Sweden · Alitretinoin Orifarm
- Slovenia · Toctino
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1c6b06f7-fcb5-48ab-a010-4d93299d358a GET /v1/drugs/1c6b06f7-fcb5-48ab-a010-4d93299d358a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65014058",
"date_amm": "2019-01-16",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "ALITRÉTINOÏNE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "capsule molle",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about alitrétinoïne.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.